What’s going on in Washington? Legislative and Enforcement Updates in the Healthcare and Life Sciences Industry
Event summary
Join Cooley FDA and legislative experts as they share FDA Enforcement trends in the life sciences space as well as discuss the recent legislative activity that life sciences companies should be aware. This panel will also discuss President Biden’s recent nomination of Dr. Robert Califf as the new FDA head and what that might mean for FDA policy and enforcement moving forward.
This webinar is part of our 2022 Life Sciences & Healthcare Innovation Program, Cooley’s 15th annual event in conjunction with the J.P. Morgan Healthcare Conference.
For more information, please email Rebecca Lanz.
Related contacts
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.